Crossmark

Heart Failure Population with Therapeutic Response to Sacubitril/Valsartan, Spironolactone and Candesartan: FDA Perspective

Published Online: 2021-10-26

Published Print: 2022-01

Authors

Gandotra, Charu https://orcid.org/0000-0001-5403-0668
Clark, Jennifer

Liu, Ququan

Senatore, Fortunato F.

Rose, Martin

Zhang, Jialu

Stockbridge, Norman L.
License Information

Text and Data Mining valid from 2021-10-26

Version of Record valid from 2021-10-26
More Information

Article History

Received: 26 July 2021

Accepted: 12 October 2021

First Online: 26 October 2021

Document is current